Kyoto, Japan

Masayuki Kohno


Average Co-Inventor Count = 4.8

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:

goldMedal2 out of 10 
 
Stella Pharma Corporation
 patents
silverMedal1 out of 815 
 
Kyoto University
 patents
bronzeMedal3 out of 832,718 
Other
 patents
where one patent can have more than one assignee

Years Active: 2013-2015

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Masayuki Kohno in Anticancer Research

Introduction

Masayuki Kohno is a prominent inventor based in Kyoto, Japan. He has made significant contributions to the field of cancer research, particularly through his innovative work on chimeric peptides. With a total of 4 patents, Kohno's inventions focus on developing effective anticancer agents.

Latest Patents

Kohno's latest patents include selective anticancer chimeric peptides that bind to the transferrin receptor. This invention aims to provide a substance that can be used as an anticancer agent or drug delivery system (DDS) with intracellular stability. The goal is to evade side effects associated with normal cells while achieving an instantaneous effect. The novel chimeric peptide targets cancer cells that overexpress EGFR by utilizing a binding peptide sequence and a lytic peptide sequence. This innovative approach effectively addresses the challenges in cancer treatment.

Another significant patent involves selective anticancer chimeric peptides that bind to the neuropilin receptor. Similar to his previous invention, this patent also aims to create a substance usable as an anticancer agent or DDS. The focus remains on ensuring intracellular stability and minimizing side effects on normal cells. By employing a chimeric peptide that includes an EGF receptor-binding peptide and a cytotoxic peptide, Kohno has made strides in targeting cancer cells effectively.

Career Highlights

Throughout his career, Masayuki Kohno has worked with various organizations, including Stella Pharma Corporation. His work has been instrumental in advancing the understanding and treatment of cancer through innovative peptide technologies.

Collaborations

Kohno has collaborated with notable individuals in the field, including Koji Kawakami and Tomohisa Horibe. These partnerships have contributed to the development of his groundbreaking inventions.

Conclusion

Masayuki Kohno's contributions to anticancer research through his innovative chimeric peptides highlight his dedication to improving cancer treatment. His work continues to inspire advancements in the field, showcasing the potential of targeted therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…